Scientists design first selective TNKS2 inhibitor to shut down WNT signaling in 8p-deleted tumors
Researchers developed the first TNKS2-selective inhibitor, TDI-012804, which suppresses WNT signaling in cancer cells lacking TNKS1 through chromosome 8p deletions ...
